Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HHIPL2 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | GPX2 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | CNPY2 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | NT5DC2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | HPCA | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | TYR | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
mRNA | SDCBP | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | VPS33B | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | GCLC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | SPR | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |